| Literature DB >> 25009536 |
Abstract
Next-generation sequencing (NGS) technologies have revolutionized modern biological and biomedical research. The engines responsible for this innovation are DNA polymerases; they catalyze the biochemical reaction for deriving template sequence information. In fact, DNA polymerase has been a cornerstone of DNA sequencing from the very beginning. Escherichia coli DNA polymerase I proteolytic (Klenow) fragment was originally utilized in Sanger's dideoxy chain-terminating DNA sequencing chemistry. From these humble beginnings followed an explosion of organism-specific, genome sequence information accessible via public database. Family A/B DNA polymerases from mesophilic/thermophilic bacteria/archaea were modified and tested in today's standard capillary electrophoresis (CE) and NGS sequencing platforms. These enzymes were selected for their efficient incorporation of bulky dye-terminator and reversible dye-terminator nucleotides respectively. Third generation, real-time single molecule sequencing platform requires slightly different enzyme properties. Enterobacterial phage ϕ29 DNA polymerase copies long stretches of DNA and possesses a unique capability to efficiently incorporate terminal phosphate-labeled nucleoside polyphosphates. Furthermore, ϕ29 enzyme has also been utilized in emerging DNA sequencing technologies including nanopore-, and protein-transistor-based sequencing. DNA polymerase is, and will continue to be, a crucial component of sequencing technologies.Entities:
Keywords: DNA polymerase; Sanger sequencing; chain terminators; next-generation sequencing; protein engineering; reversible terminators; sequencing-by-synthesis
Year: 2014 PMID: 25009536 PMCID: PMC4068291 DOI: 10.3389/fmicb.2014.00305
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Families and properties of cellular DNA replicases (Kunkel, 2004; Hübscher etal., 2010; Greenough etal., 2014).
| Polymerase family | Bacteria ( | Eukaryotes (human) | Archaea | Viruses | 3′ to 5′ exonuclease activity | **Error rate (fidelity) | Enzymes used in assays |
|---|---|---|---|---|---|---|---|
| A | Pol I [ | Pol γ (p140/p55/p55) | N.A. | T3, T5, T7 | Yes | ~10-5–10-7 | Klenow, Klen |
| B | Pol II [ | Pol α/primase (p180/p68/Pri2/Pri1) | Pol BI | HSV-1, RB69, T4, ϕ29 | Yes | ~10-6 | T4, ϕ29, |
| C | Pol III [ | N.A. | N.A. | N.A. | Yes | ~10-6 | N.A. |
| D | *N.A. | N.A. | Pol D (DP2/DP1) | N.A. | Yes | 10-4–10-5 | N.A. |
Generations of DNA polymerase-based DNA sequencing technologies.
| Institution or company | Instrumentation | Sequencing methods | Nucleotide substrates | Detection from DNA polymerase reaction |
|---|---|---|---|---|
| MRC | Sanger sequencing | DNA chain termination and fragment analysis by gel | 2′, 3′-dideoxynucleotides | Nucleotide incorporation |
| Applied biosystems/life technologies | ABI genetic analyzer series | DNA chain termination and fragment analysis by CE | Dye-terminators | Nucleotide incorporation |
| Illumina Qiagen/IBS | GA/MiSeq/HiSeq Max-Seq/Mini-20 | Stepwise SBS | Reversible dye-terminators | Nucleotide incorporation |
| *Helicos biosciences | HeliScope | Stepwise single-molecule SBS | 3′-OH unblocked reversible dye-terminators | Nucleotide incorporation |
| Pacific biosciences | PACBIO RS II | Real-time single-molecule SBS | γ-phosphate-labeled nucleotides | Nucleotide incorporation |
| Roche/454 life sciences | GS FLX/GS Junior | Sequential SBS | Nature dNTPs | PPi release |
| Ion torrent/life technologies | Ion PGM/proton | Sequential SBS | Nature dNTPs | H+ release |